Formulation of Nano-Liposomal Drug Delivery Systems for Targeted Therapy of Multi-Drug-Resistant Tuberculosis (MDR-TB). JPEHSS. 2026;4(1):431-440. doi:10.63163/jpehss.v4i1.1168